These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3096778)

  • 21. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
    Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
    Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
    Coleman P; Kettner C; Shaw E
    Biochim Biophys Acta; 1979 Jul; 569(1):41-51. PubMed ID: 111716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of plasminogen activators and the growth of cultured human tumour cells.
    Scott GK
    Int J Biochem; 1988; 20(8):817-22. PubMed ID: 3139480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
    Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
    J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of tissue plasminogen activators and urokinase by human saliva.
    Haze C; Garfunkel AA; Eldor A; Kadouri A
    Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):356-61. PubMed ID: 8015799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
    Ichinose A; Fujikawa K; Suyama T
    J Biol Chem; 1986 Mar; 261(8):3486-9. PubMed ID: 3081506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
    Golder JP; Stephens RW
    Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat testicular peritubular cells in culture secrete an inhibitor of plasminogen activator activity.
    Hettle JA; Balekjian E; Tung PS; Fritz IB
    Biol Reprod; 1988 Mar; 38(2):359-71. PubMed ID: 2833945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction of plasminogen activator of urokinase type with human serum].
    Vakulina OP; Popkova EV; Isachenkov VA
    Vopr Med Khim; 1988; 34(4):32-6. PubMed ID: 3143185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of proteases type plasminogen activator and their inhibitor in cornea.
    Mirshahi M; Mirshahi S; Soria C; Soria J; Thomaidis A; Pouliquen Y; Faure JP
    Biochem Biophys Res Commun; 1989 May; 160(3):1021-5. PubMed ID: 2499321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM; Osikowicz G; Feder S; Scheinbuks J
    J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
    Nachman RL; Hajjar KA; Silverstein RL; Dinarello CA
    J Exp Med; 1986 Jun; 163(6):1595-600. PubMed ID: 3086483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of plasminogen activators to suicide inactivation.
    Mor A; Reboud-Ravaux M; Mazaleyrat JP; Wakselman M
    Thromb Res Suppl; 1988; 8():35-44. PubMed ID: 3144767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.